← Return to feed
A compact feed for finding biotech developments worth reading at the source.
What does Bio Breakthroughs track?
Noteworthy biotech breakthroughs: successful clinical trial readouts, gene editing milestones, peptide therapy progress, FDA approvals, and genetic medicine advances.
How are items scored?
The MVP uses deterministic keyword and metadata scoring, not investment analysis. Scores are a relevance signal for feed ordering and filtering, not a measure of scientific certainty.
How are companies and tickers matched?
The ingestion job combines explicit ticker patterns, curated aliases, and article evidence. Low-confidence matches should be treated as provisional and checked against the source article.
Is this investment advice?
No. Bio Breakthroughs is a source-linked research feed for discovery and monitoring. It is not financial, medical, or legal advice.